MYL9 Antikörper (pSer20)

Produktnummer ABIN872283

Produktdetails anti-MYL9 Antikörper

Target: MYL9 (Myosin Regulatory Light Polypeptide 9 (MYL9))

Bindungsspezifität: pSer20

Reaktivität: Human, Ratte

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser MYL9 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA, Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))

Kreuzreaktivität: Human, Ratte

Homologie: Mouse,Dog,Cow,Sheep,Pig,Rabbit

Aufreinigung: Purified by Protein A.

Immunogen: KLH conjugated synthetic phosphopeptide derived from human Myosin Regulatory Light polypeptide 9 around the phosphorylation site of Ser20

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 μg/μL

Buffer: 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

Haltbarkeit: 12 months

Referenzen für anti-MYL9 Antikörper (ABIN872283)

Li, Sun, Yang, Hu, Jiang: "Tanshinone II a protects against lipopolysaccharides-induced endothelial cell injury via Rho/Rho kinase pathway." in: Chinese journal of integrative medicine, Vol. 20, Issue 3, pp. 216-23, (2014) (PubMed).

Hoj, Davis, Fullmer, Morrell, Saguibo, Schuler, Tuttle, Hansen: "Cellular contractility changes are sufficient to drive epithelial scattering." in: Experimental cell research, Vol. 326, Issue 2, pp. 187-200, (2014) (PubMed).

Ikemura, Yamamoto, Motomura, Yamaguchi, Zhao, Iwasaki, Iwamoto: "Preventive effects of the anti-vasospasm agent via the regulation of the Rho-kinase pathway on the development of steroid-induced osteonecrosis in rabbits." in: Bone, Vol. 53, Issue 2, pp. 329-35, (2013) (PubMed).

Details zu MYL9

Target: MYL9 (Myosin Regulatory Light Polypeptide 9 (MYL9))

Andere Bezeichnung: MYL9 (MYL9 Produkte)

Synonyme: LC20 antikoerper, MLC-2C antikoerper, MLC2 antikoerper, MRLC1 antikoerper, MYRL2 antikoerper, AI327049 antikoerper, MLC20 antikoerper, Mylc2c antikoerper, RLC-C antikoerper, myosin antikoerper, regulatory antikoerper, MRCL3 antikoerper, MRLC2 antikoerper, MYL9 antikoerper, zgc:103467 antikoerper, myl9 antikoerper, zgc:77916 antikoerper, myosin light chain 9 antikoerper, myosin, light polypeptide 9, regulatory antikoerper, myosin light chain 9 L homeolog antikoerper, myosin, light chain 9, regulatory antikoerper, myosin, light chain 12A, regulatory, non-sarcomeric antikoerper, myosin, light chain 9a, regulatory antikoerper, myosin, light chain 9b, regulatory antikoerper, MYL9 antikoerper, Myl9 antikoerper, myl9.L antikoerper, MYL12A antikoerper, myl9a antikoerper, myl9b antikoerper

Hintergrund:

Synonyms: LC20, MLC2, MRLC1, MYRL2, MLC-2C, Myosin regulatory light polypeptide 9, 20 kDa myosin light chain, Myosin RLC, Myosin regulatory light chain 2, smooth muscle isoform, Myosin regulatory light chain 9, Myosin regulatory light chain MRLC1, MYL9

Background: Myosin regulatory subunit that plays an important role in regulation of both smooth muscle and nonmuscle cell contractile activity via its phosphorylation. Implicated in cytokinesis, receptor capping, and cell locomotion.

Gen-ID: 10398

UniProt: P24844